Expressions of ICAM-1 and its mRNA in sera and tissues of patients with hepatocellular carcinoma  

作　　者：Jing Xu1 Ming Hui Mei1 Si En Zeng2 Qing Fen Shi3 Yong Ming Liu4 Li Ling Qin3 1Department of Hepatobiliary Surgery2Department of Pathology3Institute of Hepatobiliary Surgery4Department of Biochemistry, Guilin 541001, Guangxi Province, China 

出　　处：《World Journal of Gastroenterology》2001年第1期120-125,共6页世界胃肠病学杂志（英文版）

基　　金：Supported by the grant from the Guangxi Science;Technology Committee, No. 9811003

摘　　要：INTRODUCTIONThe increased expression of ICAM-1 on a widerange of cells and in the sera of patients withmalignancies, chronic liver diseases andinflammation diseases has been described since thelate 1980s[1-22]. Recently rapid progress in studieson expression of ICAM-1 in patients withhepatocellular carcinoma ( HCC ) have beenachieved, including clinical and experimentalresearches[23-31].

关 键 词：Carcinoma  Hepatocellular Follow-Up Studies Humans Immunohistochemistry Intercellular Adhesion Molecule-1 Liver Liver Neoplasms Predictive Value of Tests Prognosis RNA  Messenger RADIOIMMUNOASSAY Research Support  Non-U.S. Gov't Reverse Transcriptase Polymerase Chain Reaction Solubility ALPHA-FETOPROTEINS 

分 类 号：R735.7[医药卫生—肿瘤]